Search Results - Moseley, Paul

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells

    Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells by Sultana, Rebeka, Abdel-Fatah, Tarek, Perry, Christina, Moseley, Paul, Albarakti, Nada, Mohan, Vivek, Seedhouse, Claire, Chan, Stephan, Madhusudan, Srinivasan

    Published 2013
    Get full text
  2. 2
    High mobility group protein B1 is a predictor of poor survival in ovarian cancer

    High mobility group protein B1 is a predictor of poor survival in ovarian cancer by Machado, Lee R, Moseley, Paul M., Moss, Robert, Deen, Suha, Nolan, Christopher C., Spendlove, Ian, Ramage, Judith M., Chan, Stephen Y.T., Durrant, Lindy

    Published 2017
    Get full text
  3. 3
    Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy

    Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy by Al-Subhi, Nouf, Ali, Reem, Abdel-Fatah, Tarek, Moseley, Paul M., Chan, Stephen Y.T., Green, Andrew R., Ellis, Ian O., Rakha, Emad, Madhusudan, Srinivasan

    Published 2018
    Get full text
  4. 4
    Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer

    Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer by Arora, Arvind, Abdel-Fatah, Tarek, Agarwal, Devika, Doherty, Rachel, Moseley, Paul M., Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Alshareeda, Alaa, Rakha, Emad, Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan

    Published 2015
    Get full text
  5. 5
    The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response

    The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response by Barone, Giancarlo, Arora, Arvind, Ganesh, Anil, Abdel-Fatah, Tarek, Moseley, Paul, Ali, Reem, Chan, Stephen Y.T., Savva, Constantinos, Schiavone, Kristina, Carmell, Natasha, Myers, Katie N., Rakha, Emad A., Madhusudan, Srinivasan, Collis, Spencer J.

    Published 2018
    Get full text
  6. 6
    SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

    SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis by Abdel-Fatah, Tarek M.A., Agarwal, Devika, Liu, Dong-Xu, Russell, Roslin, Rueda, Oscar M., Liu, Karen, Xu, Bing, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Rees, Robert C., Caldas, Carlos, Ellis, Ian O., Ball, Graham R., Chan, Stephen Y.T.

    Published 2016
    Get full text
  7. 7
    RECQL4 helicase has oncogenic potential in sporadic breast cancers

    RECQL4 helicase has oncogenic potential in sporadic breast cancers by Arora, Arvind, Agarwal, Devika, Abdel-Fatah, Tarek M.A., Lu, Huiming, Croteau, Deborah L., Moseley, Paul, Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Rakha, Emad A., Chan, Stephen Y.T., Ellis, Ian O., Wang, Lisa L., Zhao, Yongliang, Balajee, Adayabalam S., Bohr, Vilhelm A., Madhusudan, Srinivasan

    Published 2016
    Get full text

Search Tools: